Ann: Chairman's Address and Presentation to AGM, page-120

Dolce, a couple of questions, as I wasn’t at the AGM:

1. Did they specify why the science wasn’t ‘drop-in’ for some of the existing VitD assays, as it was indicated early on it should be the case, but later identified (i think in a qtrly) they would only focus on new products. You’re indicating GC knew there would never be a chance of including AMG in existing DIASource products? Just wondering if this was specifically addressed at the AGM.

2. There seemed to be genuine surprise (based on what I’ve read here) about AS’s vote result. It wasn’t close which is kind of odd if no one on the BOD to include JM and JH were expecting this. I’m not aware of any lobbying that went on external either way (I voiced my intent to support AS here, but wouldn’t say I campaigned for him). Do you have a theory here as to why the result may have come out as it did?

Lastly, I’m glad you’re back, but you seem a bit hostile to some people here who I don’t think represent an enemy to you (I can certainly speak on my own behalf). You’re asking for a good exchange of ideas, but may seem aggressive / intimidating to the casual poster. One would think this counter productive to the community you’re trying to build. Just an observation, and offered with genuine respect.